An experimental therapy addresses aging cells in the eye that can lead to vision loss.
Two of three participants in an early clinical trial of an experimental glaucoma therapy showed improved visual field ...
In research presented this week at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, investigators from Life Biosciences Inc. reported using epigenetic reprogramming ...
BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury and ...